The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

February 29, 2004

Conditions
Carcinoma SurgeryParenteral NutritionPost-Operative Hospital Stay
Interventions
DRUG

Omega-3 fish oil emulsion (Omegaven )

Patients of the treatment group received 0.2 g fish oil (10% Omegaven, Fresenius Kabi, Bad Homburg, Germany) and 1.0 g soy bean oil per kg BW per day

DRUG

long-chain triglyceride

the control group received 1.2 g soy bean oil (Intralipid, Sino-Swed,Wuxi,China)

Trial Locations (5)

100044

People's Hospital, Beijing University, Beijing

100050

Beijing Friendship Hospital, Beijing

100730

Beijing Hospital, Beijing

Peking Union Medical College Hospital, Beijing

100853

General Hospital Of PLA, Beijing

All Listed Sponsors
lead

Sino-Swed Pharmaceutical Corporation

INDUSTRY

NCT00292279 - The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients | Biotech Hunter | Biotech Hunter